🔎 Trials Near Me

Dachaigh › Migraine › Oregon

Sgrùdaidhean clionaigeach Migraine ann an Oregon

Tha 6 sgrùdaidhean airson Migraine a’ lorg phàirtichean aig làraichean ann an Oregon.

Bailtean ann an Oregon

Teacsa sgrùdaidh oifigeil (Beurla)

Randomized Study in Children and Adolescents With Migraine: Acute Treatment

  • Providence Neuroscience Institute - Research Coordinator's Office, Portland
  • Providence St. Vincent Medical Center, Portland
A’ fastadhÌre 3
Aoisean 6 gu 17 · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT04649242

Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

  • Providence Neuroscience Institute: Research Coordinators' Office, Portland
  • Providence Pediatric Specialty Clinic, Portland
A’ fastadhÌre 3
Aoisean 6 gu 17 · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT04743141

Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study

  • Advanced Research Institute, Portland
A’ fastadhÌre 4
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 16 Sult 2026 · NCT06972056

Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

  • Providence Brain and Spine Institute /ID# 231607, Portland
A’ fastadhÌre 3
Aoisean 6 gu 17 · Gach gnè · Air ùrachadh 14 Sult 2026 · NCT05125302

A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

  • Summit Research Network, Portland
  • Advanced Research Institute - Portland, Portland
A’ fastadhÌre 3
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 20 Lùna 2026 · NCT07645924

Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old

  • Upsher-Smith Clinical Trial Site #6, Portland
  • Upsher-Smith Clinical Trials Site #7, Springfield
A’ fastadhÌre 4
Aoisean 6 gu 11 · Gach gnè · Air ùrachadh 27 Faoi 2025 · NCT04748601

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.